This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

LifePoint on Life Support

Updated from 10:45 a.m.

LifePoint (LPNT - Get Report) has taken a definite turn for the worse.

Shares dropped 15% after the rural hospital operator said profits plunged in the second quarter. Weak admissions and rising expenses, including a spike in bad debts from the uninsured, have been hammering the company's operations. LifePoint also trimmed full-year guidance.

Second-quarter income fell some 61% to $13.4 million, as escalating costs in three different areas -- bad debts, labor costs and malpractice insurance -- took a heavy toll on the bottom line. Earnings per share from continuing operations came in at 43 cents, well short of the 61-cent consensus estimate. Revenue, while up 17% to $654 million, fell shy of Wall Street targets as well.

LifePoint's skyrocketing bad-debt expense seemed to worry analysts most. At 12.4% of revenue in the latest quarter -- up from 10.2% a year ago -- it sent the company's profit margins to their lowest level in recent memory.

Moreover, LifePoint foresees ongoing challenges ahead. The company now expects to generate profits of just $2.15 to $2.25 a share for the full year. On average, analysts have been forecasting 2007 profits of $2.60 a share instead.

"While we are not satisfied with our second-quarter performance ... we are taking appropriate actions to address these issues," LifePoint CEO William Carpenter stated on Monday. "We are confident that, by investing in and working closely with the communities in which we operate, we will be able to provide the highest quality care for our patients and at the same time drive enhanced value for our shareholders."

Ultimately, Carpenter added, "we are confident in the future success of our business."

But investors clearly have their doubts. They fled the stock, sending the shares down 13% to $33.92 -- a price unseen since early this year -- in heavy trading on Monday.

Jefferies analyst Frank Morgan warned of serious pain for the hospital group as a whole.

"We expect a very negative reaction on LifePoint's reported results," Morgan wrote early Monday morning. "We are particularly concerned about the spike in bad debt. ... While this sudden increase in bad debts may still be specific to LifePoint, we expect that the entire sector will trade down based on this news."

Indeed, shares of three major hospital chains -- Community Health (CYH - Get Report), Tenet (THC - Get Report) and Universal Health (UHS - Get Report) -- all fell by more than 3% following LifePoint's warning.

Morgan has a hold recommendation on LifePoint's stock, which he valued at $42.50 ahead of the company's update. His firm makes a market in the company's securities.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CYH $19.08 0.00%
LPNT $67.56 0.00%
THC $31.69 0.00%
UHS $133.68 0.00%
AAPL $93.74 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs